HomeNON PROFIT
NON PROFIT
There are countless non-profit organizations out there that work tirelessly to improve the lives of those affected by medical conditions. It can be difficult to keep track of all of them, especially if you’re not familiar with the work they do. That’s why we’ve created this section of our website specifically for non-profit news and updates.
Here, you will find information on the latest initiatives undertaken by various non-profit groups, as well as news and updates on the progress of medical research and advocacy. We hope this section will help raise awareness about the important work being done.
ACC Clinical Trials Research Program REACH(es) New Heights
The ACC has selected 50 learners for its 2024 – 2025 Clinical Trials Research program, of whom 28 structural heart cardiologists and surgeons will participate in the CTR’s new Project REACH. This incoming cohort of learners will participate in a year-long curriculum designed to advance their skills and careers in clinical trials research and ensure that all individuals have the opportunity to contribute as part of the clinical trials research workforce.
RSNA ‘Radiology Advances’ Open-Access Journal Goes Live
Radiology Advances joins RSNA’s suite of peer-reviewed journals that includes the Society’s flagship journal, Radiology, education journal, RadioGraphics, and subspecialty journals, Radiology: Artificial Intelligence, Radiology: Cardiothoracic Imaging and Radiology: Imaging Cancer.
Data Shows Significant Prevalence of Sleep Apnea Among Cardio-Oncology Patients
Sleep apnea is a disorder of altered breathing while asleep with two types, obstructive (OSA) or central (CSA). Both can be treated to alleviate symptoms and improve cardiovascular outcomes. This study pertains to obstructive sleep apnea.
CT Scan is Most Effective to Assess People with Chest Pain
Recent randomized clinical trials have demonstrated a benefit to using CT Scan first in evaluation of these patients, and a new study being presented at the American College of Cardiology Cardiovascular Summit lends credence to this strategy, finding that CT was associated with a higher likelihood of revascularization compared to other imaging modalities or no testing.
National Association for Proton Therapy (NAPT) Welcomes CMS Rule to Improve Prior Authorization, Remains Committed to Further Improving Patient Access to Proton Therapy
National Association for Proton Therapy Executive Director Jennifer Maggiore: “For Medicare beneficiaries who need proton therapy and other advanced cancer treatments, prior authorizations create a burdensome process that often delays life-saving treatment. This new rule puts payors on notice that CMS is serious about removing barriers to care and sparing patients the frustrating and potentially harmful experience of waiting days or weeks for a coverage decision.”
SCAI, SIR, and SVS Jointly Publish Proceedings from Multispecialty Peripheral IVUS Roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were released today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), Journal of Vascular and Interventional Radiology (JVIR), and Journal of Vascular Surgery - Vascular Insights.
ACC Urges Lawmakers to Support Bill to Avoid Medicare Cuts Threatening Patient Access to Care
“We have once again arrived at American clinicians’ annual holiday tradition: urging Congress to not allow cuts to Medicare services that exacerbate financial uncertainty for practices, further threaten patient access to care, and disproportionately impact America’s rural and senior populations,” said ACC President B. Hadley Wilson, MD, FACC.
The American Kratom Association Issues Consumer Guidelines for Purchasing Kratom Products
“The AKA is calling for the FDA – Do Your Actual Job! to fulfill its statutory duty to responsibly regulate the kratom marketplace with standards consistent with other dietary and botanical supplements, and then we are launching our Consumer Guidelines for Kratom Use so consumers understand their responsibility to purchase and consume kratom products that protects their health and well-being,” Haddow concluded. “Consumers should not purchase any kratom product marketed by unscrupulous vendors who fail to properly manufacture or label their products.”
AI Model Predicts Breast Cancer Risk Without Racial Bias
Traditional breast cancer risk assessment models use information obtained from patient questionnaires, such as medical and reproductive history, to calculate a patient’s future risk of developing breast cancer.
Common Headaches Tied to Neck Inflammation
RSNA notes: The distinct underlying causes of primary headaches are still not fully understood. The most common primary headaches are tension-type headaches and migraines.
Recent News
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting
This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”